Salvational Intervention for Reducing AECOPD Under Severe Air Pollution
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a multi-center, prospective, randomized and standard treatment parallel control
clinical trial.A total of 764 stable COPD patients according to GOLD will be recruited and
equally divided into two parallel groups, salvational intervention group (SI group) and
control group (CT group).On the foundation of basic medicine, inhaled ICS/LABA will be used
as an intervention drug for patients in SI group on severe air pollution days. It is aimed to
evaluate whether this novel treatment strategy will decrease the frequency of AECOPD per
year.
Phase:
N/A
Details
Lead Sponsor:
Peking University First Hospital
Collaborators:
Aerospace 731 Hospital Beijing Changping Hospital Beijing Jingmei Group General Hospital Beijing Jishuitan Hospital Beijing Luhe Hospital Beijing Miyun Hospital Civil Aviation General Hospital Peking University Shougang Hospital People's Hospital of Beijing Daxing District People’s Hospital of Beijing Daxing District The Hospital of Shunyi District Beijing